Seres Therapeutics, Inc.
MCRB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001609809
In the last 90 days, Seres Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $17.9M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Seres Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 131 | 3 | 123 | −5 |
| Shares | 75.5M | 91.0K | 90.9M | +15.5M (+20.6%) |
| Value | $537.2M | $648.0K | $312.7M | −$223.9M (−41.7%) |
3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held Seres Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| CVI Holdings, LLC | 2,722,826 | $9.34M | 0.68% |
| Maven Securities LTD | 1,154,507 | $3.96M | 0.70% |
| Marshall Wace, LLP | 340,890 | $1.17M | 0.00% |
| Point72 Asset Management, L.P. | 335,000 | $1.15M | 0.01% |
| Acadian Asset Management LLC | 131,774 | $452.0K | 0.00% |
| Parallax Volatility Advisers, L.P. | 100,000 | $343.0K | 0.00% |
| Walleye Capital LLC | 99,950 | $343.0K | 0.01% |
| Caxton Associates LP | 79,239 | $272.0K | 0.03% |
| Ergoteles LLC | 72,542 | $249.0K | 0.01% |
| Prudential Financial Inc | 39,550 | $136.0K | 0.00% |
| Squarepoint Ops LLC | 37,897 | $130.0K | 0.00% |
| Rothschild Investment Corp | 29,000 | $99.0K | 0.01% |
| Raymond James & Associates | 18,890 | $65.0K | 0.00% |
| Centiva Capital, LP | 14,643 | $50.0K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 14,326 | $49.0K | 0.01% |
| Crewe Advisors LLC | 676 | $2.00K | 0.00% |
| First Horizon Advisors, Inc. | 287 | $1.00K | 0.00% |
| Bell Investment Advisors, Inc | 36 | $0 | 0.00% |
Sold out (23)
Institutions that held Seres Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Soviero Asset Management, LP | 360,000 | $2.56M |
| Adage Capital Partners GP, L.L.C. | 300,000 | $2.14M |
| Rafferty Asset Management, LLC | 296,435 | $2.11M |
| Putnam Investments LLC | 194,782 | $1.39M |
| Oregon Public Employees Retirement Fund | 89,274 | $636.0K |
| American Century Companies Inc | 75,410 | $537.0K |
| Edgewood Management LLC | 70,000 | $498.0K |
| DekaBank Deutsche Girozentrale | 67,000 | $482.0K |
| Engineers Gate Manager LP | 56,974 | $406.0K |
| Jane Street Group, LLC | 19,160 | $137.0K |
| Trexquant Investment LP | 17,719 | $126.0K |
| E Fund Management Co., Ltd. | 14,871 | $106.0K |
| Blueshift Asset Management, LLC | 10,294 | $73.0K |
| TCI Wealth Advisors, Inc. | 519 | $4.00K |
| US Bancorp | 249 | $2.00K |
| Kayne Anderson Rudnick Investment Management LLC | 247 | $2.00K |
| Massmutual Trust Co FSB | 349 | $2.00K |
| Signaturefd, LLC | 327 | $2.00K |
| CWM, LLC | 225 | $2.00K |
| Bessemer Group Inc | 139 | $1.00K |
| Captrust Financial Advisors | 101 | $1.00K |
| Quadrant Capital Group LLC | 87 | $1.00K |
| Capital Advisors, Ltd. LLC | 11 | $0 |
Not filed for Q2 2022 yet (3)
Institutions that held Seres Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Susquehanna Fundamental Investments, LLC | 52,988 | $377.0K |
| Parametric Portfolio Associates LLC | 26,654 | $190.0K |
| Amalgamated Financial Corp. | 11,332 | $81.0K |